Targeting EGFR signalling in chronic lung disease: Therapeutic challenges and opportunities

European Respiratory Journal

Volumn 44, Issue 2, 2014, Pages 513-522

  Vallath, Sabari ^a   Hynds, Robert E ^a   Succony, Laura ^a   Janes, Sam M ^a   Giangreco, Adam ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

AIRWAY HYPERSECRETORY DISEASE; CAUSE OF DEATH; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; DISEASE MODEL; DRUG TARGETING; ETHNIC GROUP; EUROPE; EUROPEAN; HOMEOSTASIS; HUMAN; LUNG CANCER; LUNG DEVELOPMENT; LUNG FIBROSIS; MOLECULAR BIOLOGY; MORPHOGENESIS; NONHUMAN; ONTOGENY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RESPIRATORY TRACT DISEASE; REVIEW; SIGNAL TRANSDUCTION; TISSUE REPAIR; ANIMAL; ANTAGONISTS AND INHIBITORS; CHRONIC DISEASE; INFLAMMATION; LUNG; LUNG DISEASE; LUNG TUMOR; METABOLISM; MOUSE; PHYSIOLOGY; TREATMENT OUTCOME;

ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; LUNG; LUNG DISEASES; LUNG NEOPLASMS; MICE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY FIBROSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84901359590     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00146413     Document Type: Review

References (93)

1. Loddenkemper R, Gibson GJ, Sibille Y. European Lung White Book: The First Comprehensive Survey on Respiratory Health in Europe. Sheffield, European Respiratory Society, 2003.
2. Ask K, Eickelberg O, Gauldie J, et al. Have advanced research technologies made real impact on respiratory medicine? Respirology 2010; 15: 876-880.
3. Fingerlin TE, Murphy E, Zhang W, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 2013; 45: 613-620.
4. Pleasance ED, Stephens PJ, O'Meara S, et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010; 463: 184-190.
5. Soler Artigas M, Loth DW, Wain LV, et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 2011; 43: 1082-1090.
6. Wilk JB, Shrine NR, Loehr LR, et al. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med 2012; 186: 622-632.
7. Wills-Karp M, Ewart SL. Time to draw breath: asthma-susceptibility genes are identified. Nat Rev Genet 2004; 5: 376-387. (Pubitemid 38529409)
8. Lee AJ, Swanton C. Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics. Biochem Pharmacol 2012; 83: 1013-1020.
9. Sharma SV, Bell DW, Settleman J, et al. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 2007; 7: 169-181.
10. Burgel PR, Nadel JA. Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur Respir J 2008; 32: 1068-1081.
11. Lai HY, Rogers DF. Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy. Curr Opin Allergy Clin Immunol 2010; 10: 67-76.
12. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001; 2: 127-137. (Pubitemid 33674041)
13. Zhang H, Berezov A, Wang Q, et al. ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest 2007; 117: 2051-2058. (Pubitemid 47224766)
14. Graus-Porta D, Beerli RR, Daly JM, et al. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 1997; 16: 1647-1655. (Pubitemid 27151960)
15. Lemmon MA. Ligand-induced ErbB receptor dimerization. Exp Cell Res 2009; 315: 638-648.
16. Jorissen RN, Walker F, Pouliot N, et al. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 2003; 284: 31-53. (Pubitemid 36331965)
17. Wilson KJ, Gilmore JL, Foley J, et al. Functional selectivity of EGF family peptide growth factors: implications for cancer. Pharmacol Ther 2009; 122: 1-8.
18. Higashiyama S, Iwabuki H, Morimoto C, et al. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. Cancer Sci 2008; 99: 214-220. (Pubitemid 351228472)
19. Sahin U, Weskamp G, Kelly K, et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 2004; 164: 769-779. (Pubitemid 38282960)
20. Horiuchi K, Le Gall S, Schulte M, et al. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol Biol Cell 2007; 18: 176-188. (Pubitemid 46066719)
21. Prenzel N, Zwick E, Daub H, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999; 402: 884-888.
22. Yu WH, Woessner JF Jr, McNeish JD, et al. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 2002; 16: 307-323. (Pubitemid 34111411)
23. Vermeer PD, Einwalter LA, Moninger TO, et al. Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. Nature 2003; 422: 322-326. (Pubitemid 36378360)
24. Shaykhiev R, Zuo WL, Chao I, et al. EGF shifts human airway basal cell fate toward a smoking-associated airway epithelial phenotype. Proc Natl Acad Sci USA 2013; 110: 12102-12107.
25. Jensen KB, Watt FM. Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence. Proc Natl Acad Sci USA 2006; 103: 11958-11963. (Pubitemid 44215793)
26. Jensen KB, Collins CA, Nascimento E, et al. Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis. Cell Stem Cell 2009; 4: 427-439.
27. Wong VW, Stange DE, Page ME, et al. Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling. Nat Cell Biol 2012; 14: 401-408.
28. Lu L, Teixeira VH, Yuan Z, et al. LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development. J Pathol 2013; 229: 608-620.
29. Zhang X, Pickin KA, Bose R, et al. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 2007; 450: 741-744. (Pubitemid 350207680)
30. Avraham R, Yarden Y. Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nat Rev Mol Cell Biol 2011; 12: 104-117.
31. Goh LK, Huang F, Kim W, et al. Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor. J Cell Biol 2010; 189: 871-883.
32. Eden ER, Huang F, Sorkin A, et al. The role of EGF receptor ubiquitination in regulating its intracellular traffic. Traffic 2012; 13: 329-337.
33. Singh AB, Harris RC. Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal 2005; 17: 1183-1193. (Pubitemid 40984037)
34. Roepstorff K, Grandal MV, Henriksen L, et al. Differential effects of EGFR ligands on endocytic sorting of the receptor. Traffic 2009; 10: 1115-1127.
35. Korfhagen TR, Swantz RJ, Wert SE, et al. Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice. J Clin Invest 1994; 93: 1691-1699. (Pubitemid 24116410)
36. Miettinen PJ, Warburton D, Bu D, et al. Impaired lung branching morphogenesis in the absence of functional EGF receptor. Dev Biol 1997; 186: 224-236. (Pubitemid 27319571)
37. Le Cras TD, Hardie WD, Fagan K, et al. Disrupted pulmonary vascular development and pulmonary hypertension in transgenic mice overexpressing transforming growth factor-alpha. Am J Physiol Lung Cell Mol Physiol 2003; 285: L1046-L1054. (Pubitemid 37310094)
38. Madtes DK, Elston AL, Hackman RC, et al. Transforming growth factor-alpha deficiency reduces pulmonary fibrosis in transgenic mice. Am J Respir Cell Mol Biol 1999; 20: 924-934. (Pubitemid 129544270)
39. Plopper CG, St George JA, Read LC, et al. Acceleration of alveolar type II cell differentiation in fetal rhesus monkey lung by administration of EGF. Am J Physiol 1992; 262: L313-L321.
40. Finigan JH, Downey GP, Kern JA. Human epidermal growth factor receptor signaling in acute lung injury. Am J Respir Cell Mol Biol 2012; 47: 395-404.
41. Patel NV, Acarregui MJ, Snyder JM, et al. Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro. Am J Respir Cell Mol Biol 2000; 22: 432-440. (Pubitemid 30343342)
42. Liu W, Volpe MA, Zscheppang K, et al. ErbB4 regulates surfactant synthesis and proliferation in adult rat pulmonary epithelial cells. Exp Lung Res 2009; 35: 29-47.
43. Zscheppang K, Dork T, Schmiedl A, et al. Neuregulin receptor ErbB4 functions as a transcriptional cofactor for the expression of surfactant protein B in the fetal lung. Am J Respir Cell Mol Biol 2011; 45: 761-767.
44. Zscheppang K, Liu W, Volpe MV, et al. ErbB4 regulates fetal surfactant phospholipid synthesis in primary fetal rat type II cells. Am J Physiol Lung Cell Mol Physiol 2007; 293: L429-L435. (Pubitemid 47205023)
45. Vermeer PD, Panko L, Karp P, et al. Differentiation of human airway epithelia is dependent on erbB2. Am J Physiol Lung Cell Mol Physiol 2006; 291: L175-L180. (Pubitemid 44148101)
46. LeSimple P, van Seuningen I, Buisine MP, et al. Trefoil factor family 3 peptide promotes human airway epithelial ciliated cell differentiation. Am J Respir Cell Mol Biol 2007; 36: 296-303. (Pubitemid 46365280)
47. Hardie WD, Bruno MD, Huelsman KM, et al. Postnatal lung function and morphology in transgenic mice expressing transforming growth factor-alpha. Am J Pathol 1997; 151: 1075-1083. (Pubitemid 27424317)
48. Andrianifahanana M, Wilkes MC, Gupta SK, et al. Profibrotic TGFb responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases. FASEB J 2013; 27: 4444-4454.
49. Ishii Y, Fujimoto S, Fukuda T. Gefitinib prevents bleomycin-induced lung fibrosis in mice. Am J Respir Crit Care Med 2006; 174: 550-556. (Pubitemid 44330548)
50. Takeyama K, Fahy JV, Nadel JA. Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. Am J Respir Crit Care Med 2001; 163: 511-516. (Pubitemid 32158538)
51. O'Donnell RA, Richter A, Ward J, et al. Expression of ErbB receptors and mucins in the airways of long term current smokers. Thorax 2004; 59: 1032-1040. (Pubitemid 39573921)
52. Burgel PR, Montani D, Danel C, et al. A morphometric study of mucins and small airway plugging in cystic fibrosis. Thorax 2007; 62: 153-161.
53. Kohri K, Ueki IF, Shim JJ, et al. Pseudomonas aeruginosa induces MUC5AC production via epidermal growth factor receptor. Eur Respir J 2002; 20: 1263-1270. (Pubitemid 35331887)
54. Shao MX, Ueki IF, Nadel JA. Tumor necrosis factor alpha-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci USA 2003; 100: 11618-11623. (Pubitemid 37205985)
55. Blanchet S, Ramgolam K, Baulig A, et al. Fine particulate matter induces amphiregulin secretion by bronchial epithelial cells. Am J Respir Cell Mol Biol 2004; 30: 421-427. (Pubitemid 38457174)
56. Rumelhard M, Ramgolam K, Auger F, et al. Effects of PM2.5 components in the release of amphiregulin by human airway epithelial cells. Toxicol Lett 2007; 168: 155-164. (Pubitemid 46075174)
57. Rose MC, Piazza FM, Chen YA, et al. Model systems for investigating mucin gene expression in airway diseases. J Aerosol Med 2000; 13: 245-261.
58. Takeyama K, Dabbagh K, Lee HM, et al. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci USA 1999; 96: 3081-3086. (Pubitemid 29148847)
59. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev 2004; 202: 175-190. (Pubitemid 39576912)
60. Booth BW, Adler KB, Bonner JC, et al. Interleukin-13 induces proliferation of human airway epithelial cells in vitro via a mechanism mediated by transforming growth factor-alpha. Am J Respir Cell Mol Biol 2001; 25: 739-743. (Pubitemid 33124691)
61. Burgel PR, Lazarus SC, Tam DC, et al. Human eosinophils induce mucin production in airway epithelial cells via epidermal growth factor receptor activation. J Immunol 2001; 167: 5948-5954. (Pubitemid 33062791)
62. Val S, Belade E, George I, et al. Fine PM induce airway MUC5AC expression through the autocrine effect of amphiregulin. Arch Toxicol 2012; 86: 1851-1859.
63. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350: 2129-2139. (Pubitemid 38637993)
64. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004; 304: 1497-1500. (Pubitemid 38720929)
65. Meuwissen R, Berns A. Mouse models for human lung cancer. Genes Dev 2005; 19: 643-664. (Pubitemid 40395076)
66. Regales L, Gong Y, Shen R, et al. Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer. J Clin Invest 2009; 119: 3000-3010.
67. Ferby I, Reschke M, Kudlacek O, et al. Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation. Nat Med 2006; 12: 568-573.
68. Reschke M, Ferby I, Stepniak E, et al. Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma. Hepatology 2010; 51: 1383-1390.
69. Hopkins S, Linderoth E, Hantschel O, et al. Mig6 is a sensor of EGF receptor inactivation that directly activates c- Abl to induce apoptosis during epithelial homeostasis. Dev Cell 2012; 23: 547-559.
70. Jin N, Cho SN, Raso MG, et al. Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis. Development 2009; 136: 3347-3356.
71. Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009; 361: 947-957.
72. Maemondo M, Inoue A, Kobayashi K, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 2010; 362: 2380-2388.
73. Hanna N, Lilenbaum R, Ansari R, et al. Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer. J Clin Oncol 2006; 24: 5253-5258. (Pubitemid 46631370)
74. Kobayashi S, Boggon TJ, Dayaram T, et al. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med 2005; 352: 786-792. (Pubitemid 40271173)
75. Jiang F, Qiu Q, Khanna A, et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res MCR 2009; 7: 330-338.
76. Huang CP, Tsai MF, Chang TH, et al. ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Cancer Lett 2013; 328: 144-151.
77. Engelman JA, Zejnullahu K, Mitsudomi T, et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 2007; 316: 1039-1043. (Pubitemid 46799492)
78. Hirsh V. Afatinib (BIBW 2992) development in non-small-cell lung cancer. Future Oncol 2011; 7: 817-825.
79. Motzer RJ, Escudier B, Oudard S, et al. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 2008; 372: 449-456.
80. Madala SK, Schmidt S, Davidson C, et al. MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation. Am J Respir Cell Mol Biol 2012; 46: 380-388.
81. Le Cras TD, Korfhagen TR, Davidson C, et al. Inhibition of PI3K by PX-866 prevents transforming growth factor-alpha- induced pulmonary fibrosis. Am J Pathol 2010; 176: 679-686.
82. Korfhagen TR, Le Cras TD, Davidson CR, et al. Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2009; 41: 562-572.
83. Simler NR, Howell DC, Marshall RP, et al. The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats. Eur Respir J 2002; 19: 1124-1127. (Pubitemid 34649629)
84. Malouf MA, Hopkins P, Snell G, et al. An investigator-driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis. Respirology 2011; 16: 776-783.
85. Cervantes F, Martinez-Trillos A. Myelofibrosis: an update on current pharmacotherapy and future directions. Expert Opin Pharmacother 2013; 14: 873-884.
86. Zhang J, Bi M, Zhong F, et al. Role of CIP4 in high glucose induced epithelial-mesenchymal transition of rat peritoneal mesothelial cells. Ren Fail 2013; 35: 989-995.
87. Yoshisue H, Hasegawa K. Effect of MMP/ADAM inhibitors on goblet cell hyperplasia in cultured human bronchial epithelial cells. Biosci Biotechnol Biochem 2004; 68: 2024-2031. (Pubitemid 39547590)
88. Li N, Li Q, Zhou XD, et al. Chronic mechanical stress induces mucin 5AC expression in human bronchial epithelial cells through ERK dependent pathways. Mol Biol Rep 2012; 39: 1019-1028.
89. Woodruff PG, Wolff M, Hohlfeld JM, et al. Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181: 438-445.
90. Cohen MH, Williams GA, Sridhara R, et al. FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets. Oncologist 2003; 8: 303-306. (Pubitemid 36929716)
91. Takano T, Ohe Y, Kusumoto M, et al. Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinib. Lung Cancer 2004; 45: 93-104. (Pubitemid 38757837)
92. Teramoto S, Yamamoto H, Ouchi Y. Clinical efficacy and toxicity of gefitinib in patients with lung cancer. Lancet 2003; 361: 1992-1993. (Pubitemid 36694602)
93. Kudoh S, Kato H, Nishiwaki Y, et al. Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study. Am J Respir Crit Care Med 2008; 177: 1348-1357. (Pubitemid 351860912)